Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Telling the time of day by color

  • Half of older adults in US now taking aspirin, survey shows

  • Young women objectify themselves more browsing Facebook, magazines than media types

  • Artificial blood vessel lets researchers better assess clot removal devices

  • Protecting students from homophobic bullying

  • Importance of counselling in those affected by infertility

  • Two drugs reduce teacher-rated anxiety, in addition to ADHD, aggression

  • Diabetes perceptions vary according to risk factors, researchers find

  • Text messages a good way to support mothers with postpartum depression

  • One-third of women with ADHD report being sexually abused during childhood

  •